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One of the most important conceptual advances of the past 
several years was the identification of protein components 
required for membrane fusion events during intracellular 
transport (Rothman, 1994). Through the combination of 
biochemistry, molecular biology, and genetics now typical 
of modern cell biology, a remarkable complex of proteins 
has been confirmed as playing an essential role in mem- 
brane fusion both in vitro and in intact cells. The first mem- 
ber of this complex, N-ethylmalemide (NEM)-sensitive fac- 
tor (NSF), was first purified some years ago by Rothman 
and colleagues on the basis of its being an NEM-sensitive 
protein required for vesicular transport or fusion, or both, 
in a cell-free assay that measured transport through the 
Golgi complex. Critical corroboration of the in vivo impor- 
tance of NSF, an ATPase, was provided by the finding that 
mutations in its yeast homolog, Sec18p, similarly blocked 
transport hrough the secretory pathway. Rothman's group 
went on to isolate several other proteins with which NSF 
must interact to perform its function. These include the 
SNAPs (~, ~, and Y), soluble proteins required for NSF 
attachment o membranes, as well as the cognate mem- 
brane receptors for the presumptive NSF-SNAP complex. 
These SNAP receptors were termed SNAREs (SSIIner et 
al., 1993). 
Almost immediately, it became obvious that both the 
SNAPs and SNAREs are members of large protein fami- 
lies that function in diverse organelles and species (Ben- 
nett and Scheller, 1993). Most importantly, many of the 
well-characterized protein components of the synaptic 
vesicle and presynaptic membranes, worked on for years 
by neurobiologists, were actually members of the com- 
plex (Bennett and Scheller, 1994). Indeed, isolation of the 
SNAREs was ultimately accomplished from brain. The 
synaptic SNAREs come in two forms, corresponding to the 
synaptic vesicle-associated protein synaptobrevin-VAMP 
and the presynaptic membrane proteins syntaxin and 
SNAP-25. As a result, the "SNARE hypothesis" was devel- 
oped, predicting the existence of a v-SNARE (on the vesic- 
ular carrier) and a t-SNARE (on the target membrane) 
whose interaction in a complex with SNAPs and NSF 
would be the major determinant of vesicle docking and 
subsequent fusion (Rothman and Warren, 1994). Forma- 
tion and function of the complex are regulated by a series 
of accessory proteins that may not interact directly with 
it, including synaptotagmin (thought o confer the Ca 2+ sen- 
sitivity of synaptic vesicle exocytosis, at least in neurons), 
the ubiquitous proteins p115 and Seclp, and members 
of the Rab family of monomeric GTPases (Ferro-Novick 
and Jahn, 1994) (Figure 1). 
The precise function of the SNARE complex, its individ- 
ual components, or any of its accessory proteins remains 
to be characterized. However, it is clear that they define 
a common mechanism underlying vesicular targeting, 
docking, or fusion (or some combination of these) events 
responsible for transport between many, if not all, or- 
ganelles (Figure 1). Homologs of both t-SNAREs and 
v-SNAREs (short coiled-coil domain-type membrane pro- 
teins with COOH-terminal anchors) have been found on 
diverse organelles and associated genetically with differ- 
ent transport steps. Similarly, the Rab family consists of 
>30 closely related members with organelle-specific as- 
signments and functions. Indeed, there is excellent func- 
tional and genetic evidence that NSF, individual Rab pro- 
teins, and individual cognate v-SNARE and t-SNARE 
homologs are important in steps ranging from transport 
between the endoplasmic reticulum (ER) and the Golgi 
complex, the Golgi and lysosomes, endosomes, and fu- 
sion of several types of vesicles at the plasma membrane. 
A single NSF appears to be a common thread throughout 
these various reactions, each of which may involve pair- 
wise combinations of multiple SNARE proteins. 
Lest one be tempted, however, to conclude that all intra- 
cellular fusion events represent simple variations on a 
common theme in the manner of Beethoven's Diabelli Vari- 
ations or Brahms' Variations on a Theme by Hayden, more 
recent results- including three papers in this week's issue 
of Ceil--suggest otherwise. Either entirely unique themes 
also exist, or the variations can be far more convoluted, 
in the manner of Elgar's Enigma Variations. The first indica- 
tion that this might be the case came from the observation 
that, in the polarized MDCK epithelial cell line, fusion of 
transport vesicles from the Golgi complex with the apical 
plasma membrane involved a mechanism that was signifi- 
cantly different, being independent of NSF, SNAPs, or 
even Rab proteins (Ikonen et al., 1995). In contrast, fusion 
of Golgi-derived, basolaterally targeted vesicles involved 
each of these components. Unfortunately, no information 
is yet available concerning the likely protein components 
responsible for docking, fusion, or both with the apical 
plasma membrane. Since epithelial cell-specific annexins 
have been found at this membrane domain, it is not incon- 
ceivable that one or more members of this class of pro- 
teins, which have occasionally been associated with fu- 
sion events in vitro, may play a role. 
More complete information, however, has now illus- 
trated the existence of a second mechanism, or at least 
one which represents a more complex variation of the origi- 
nal NSF-based SNARE scheme. Following mating in the 
yeast Saccharomyces cerevisiae, nuclear envelope fusion 
must occur, a process referred to as karyogamy. This pro- 
cess can be approximated in vitro using an assay of ER 
fusion, the ER being continuous with the nuclear envelope. 
Last year, Schekman and colleagues found that neither 
in intact cells nor in vitro were the products of genes encod- 
ing NSF (SEC18) or SNAP (SEC17) required for nuclear- 
ER membrane fusion (Latterich and Schekman, 1994). 
Now, they have identified both genetically and biochemi- 
cally at least one protein that is required: the product of 
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Figure 1. NSF/SNAP-Mediated Vesicle Docking or Fusion 
The basic components hought to be involved in the NSF-dependent 
docking or fusion of transport vesicles with their target membrane 
include the following: the vesicle v-SNARE (synaptobrevin/VAMP in 
the synapse), the complementary t-SNARE on the target (e.g., syntaxin 
or SNAP-25) together in a complex with NSF, SNAP (Q, 13, or -f), and 
the synaptic vesicle membrane protein synaptotagrnin. Functionally, 
but apparently not physically, associated with this complex are a 
GTPase of the Rab family (Rab3 in neurons) and a ubiquitous soluble 
protein designated p115. It is unclear whether the formation of this 
complex is necessary and sufficient for initial vesicle docking, vesicle 
fusion, or both activities. A number of the transport steps thought to 
be mediated by the NSF/SNAP complex in conjunction with organelle- 
specific SNAREs is included together with an indication of whether 
these steps involve intercompartmental (heterotypic) orintracompart- 
mental (homotypic) transport. 
the cell division cycle gene CDC48 (Latterich et al., 1995 
[this issue of Cell]). cdc48 mutants are arrested late in 
mitosis and accumulate longated nuclei that appear un- 
able to undergo fission, a process that must also involve 
fusion. Interestingly, the sequence of Cdc48p exhibits sig- 
nificant homology to yeast and mammalian NSF. Although 
sequence identity is <35% overall, it is significantly higher 
in individual domains (50%), particularly within the dupli- 
cated nucleotide-binding domain characteristic of NSF 
(FrShlich et al., 1991). 
The in vitro ER fusion assay developed by Latterich et al. 
involves equestering ct factor (a secretory glycoprotein) in 
the ER of yeast defective in glucosidase and seeking fu- 
sion with glucosidase-positive ER (assayed by deglucosy- 
lation of the ot factor). ERs isolated from strains harboring 
a temperature-sensitive allele of cdc48 were found to ex- 
hibit a temperature-sensitive d fect in the in vitro fusion 
assay. The defect could be complemented by adding wild- 
type Cdc48p or inhibited by anti-Cdc48p antibodies. Since 
the signal obtained in the in vitro assay was relatively small 
(15%-20% of total), one cannot be certain that the CDC48- 
dependent reaction explains all of the fusion activities that 
may be associated with the ER or nuclear envelope. In- 
deed, the cdc48 mutant cells apparently do not exhibit he 
karyogamy phenotype, suggesting that Cdc48p may be 
less important for initial nuclear fusion in vivo than for 
nuclear fission just prior to cytokinesis. 
Animal cells similarly exhibit at least one membrane 
docking/fusion step that is dependent on the mammalian 
Cdc48p homolog, valosin-containing protein (VCP) or, more 
simply, p97 (Peters et al., 1990). During mitosis, there is a 
cessation of virtually all membrane traffic on the endocytic 
and secretory pathways. This is accompanied by the gen- 
eral breakdown of complex organelles into small vesicles 
that rapidly reassemble after telophase. This reassembly 
process has been at least partially reconstituted in vitro 
using Golgi complex membranes dissociated by incuba- 
tion in mitotic cytosol or in the drug ilimiquinone (Acharya 
et al., 1995 [this issue of Cell]; Rabouille et al., 1995 [this 
issue of Cell]). Although classical Golgi stacks do not effi- 
ciently reform in these assays, individual cisternae do as- 
semble and lengthen characteristically as indicated by im- 
munofluorescence or electron microscopy. While these in 
vitro reactions were found to be sensitive to NEM, work 
from both Malhotra and Warren clearly demonstrate that 
sensitivity to this alkylating reagent was not due entirely 
to NSF. Taking a hint from the yeast work, a role for p97 
was illustrated by the fact that the complete assembly re- 
action required the addition of both p97 and NSF/SNAPs. 
In neither case is it clear which step(s) in the reassembly 
process is p97 dependent rather than NSF dependent, 
although the two systems may work sequentially. The ex- 
periments suggest either that NSF is required for the co- 
alescence of small vesicles into stack precursors while 
p97 is required for final cisternal assembly, or vice versa. 
Although it will be important o resolve this issue to under- 
stand the process of Golgi assembly, of greater signifi- 
cance is the very existence of a second docking/fusion 
system that exists separately or in parallel to the NSF/ 
SNAP system. 
Despite the structural homology, NEM sensitivities, and 
ATPase activities of NSF and p97, initial indications are 
that the two proteins are quite different in their modes of 
action. Clearly, p97 does not simply represent a second 
isoform of NSF that plugs in to the same SNAP/SNARE 
system. In vitro, p97-mediated Golgi assembly did not re- 
quire exogenous SNAP (or any other protein, for that mat- 
ter). Even more interestingly, the p97 step did not require 
a member of the Rab family, a feature common to all known 
NSF-dependent reactions (Acharya et al., 1995). Nor- 
mally, the addition of the generalized Rab-binding protein 
GDI (guanine nucleotide dissociation inhibitor) prevents 
NSF-dependent membrane fusion events in vitro by re- 
moving a Rab protein from either or both of the intended 
fusion partners. Addition of GDI to the p97 reaction, how- 
ever, was found to be without effect. GTP~,S, another 
GTPase inhibitor/activator, was also without effect. While 
this result does not completely eliminate a possible role 
for Rab proteins or their friends in p97-mediated Golgi 
reassembly, it does suggest that this NSF-like protein acts 
by coupling with components that may be entirely distinct 
from the accessory proteins needed of NSF-mediated re- 
actions (Figure 2). 
Why would cells possess at least two apparently distinct 
mediators of membrane fusion? This is a particularly vex- 
ing question given the flexibility exhibited by the NSF/ 
SNAP complex, being able to catalyze docking/fusion 
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Figure 2. p97/CDC46p-Mediated Vesicle Docking or Fusion 
By analogy to the much better characterized NSF/SNAP-dependent 
mechanism, the p97/CDC48p-based system of vesicle docking/fusion 
is pictured as involving soluble p97/CDO48p associating with cognate 
SNAREs, i.e., membrane receptors for p97/CDC48p on both fusion 
partners. If p97/CDC48p mediates only hemotypic fusion events, then 
it is possible that the receptors on the "transport vesicle" and "target 
membrane" are in fact the same protein. These receptors have not 
been identified, nor is it known whether p97/CDC48p interacts with 
any other soluble or membrane proteins. 
events at diverse steps during both endocytosis and secre- 
tion. One attractive possibility is that the NSF- and p97/ 
Cdc48-dependent fusion events distinguish between two 
teleologically distinct classes of membrane fusion, hetero- 
typic and homotypic fusion (Latterich et al., 1995). Hetero- 
typic fusion can be characterized as describing transport 
events that occur between organelle compartments. For 
example, transport from the ER to the cis-Golgi network 
represents transport across a compartmental boundary. 
Such events may be viewed as being controlled by NSF. 
Hornotypic fusion, on the other hand, can be operationally 
defined as the fusion between "like" membranes, such as 
the ER-ER fusion assay used by Letterich et al. Such 
events, obviously necessary to maintain the dynamic in- 
tegrity of virtually all organelles, might be under the control 
of the p97/Cdc48p-type system. Reassembly of Golgi cis- 
ternae would be an example of this type of situation, and 
thus might depend on both NSF and p97/Cdc48p, perhaps 
because it involves steps analogous to transport between 
stacks as well as cisternal elongation (Figures 1 and 2). 
While individual cisternae in any one Golgi stack presum- 
ably represent single compartments, the Golgi complex 
itself is almost certainly comprised of multiple compart- 
ments (Mellman and Simons, 1992). If p97/Cdc48p is in- 
volved in homotypic fusion events, then the cognate 
SNAREs, or p97/Cdc48p receptors, are likely to be identi- 
cal on both fusion partners (Figure 2). Conceivably, it may 
be advantageous to cells to regulate homotypic and het- 
erotypic fusion events independently. 
The heterotypic versus homotypic paradigm appears to 
be inconsistent, however, with what is known about the 
fusion of endosomes in vitro. Like the ER fusion assay, 
endosorne fusion in vitro has been operationally defined 
to measure homotypic fusion between identical early en- 
dosome populations. Clearly, these reactions depend, at 
least in part, on Rab proteins as well as NSF (Gorvel et 
al., 1991 ; Rodriguez et al., 1994). Although a possible role 
for p97/Cdc48p has not been determined, Rab5-depen- 
dent fusion is exceedingly efficient, making it difficult to 
accommodate the need for a second, completely indepen- 
dent fusion mechanism. On the other hand, there is often 
a bothersome "background" activity in endosome fusion 
assays as well as evidence for one or more non-NSF NEM- 
sensitive components (Rodriguez et al., 1994). Thus, it is 
possible that there are both homotypic and heterotypic 
components to what is defined, operationally only, as an 
assay of homotypic fusion. This is a general conceptual 
difficulty even with the ER and Golgi assays, since fusion 
events are defined somewhat arbitrarily as homotypic or 
heterotypic by the experimental manipulations of the in- 
vestigator, as opposed to the biochemical features of the 
membranes under consideration. 
In any event, it is clear that p97/Cdc48p plays an im- 
portant and critical role in mediating fusion events in at 
least two organelles, the ER-nuclear envelope and the 
Golgi complex. If the leitmotif established by NSF is any 
guide, one can assume that even if a single p97/Cdc48p 
species is responsible for both (and perhaps other) activi- 
ties, p97/Cdc48p is not likely to act alone. The search is 
now on to identify the likely accessory molecules with 
which p97/Cdc48p interacts, the functional analogs of 
SNAPs and SNAREs. There may even be other p97/ 
Cdc48p family members, as has already been suggested 
by the existence of a yeast mutant (pasl) in peroxisome 
biogenesis that affects a homologous protein (Erdmann et 
al., 1991). pasl mutants appear incapable of assembling 
large peroxisomes from smaller precursors. Moreover, the 
fact that cdc48 mutants do not exhibit a dramatic karyog- 
amy-type defect suggests that the initial fusion of nuclear 
envelopes after mating may not be directly dependent on 
CDC48, which may more directly control the fusion event 
needed for nuclear fission. Solution to these problems will 
reveal the extent o which the p97/Cdc48p system exhibits 
variations on its own theme as well as the extent o which 
it is a somewhat more enigmatic variation on a theme 
whose melody is a bit more familiar. 
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